Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T08:05:44.359Z Has data issue: false hasContentIssue false

The distribution of complement-fixing antibody and growth-inhibiting antibody to Mycoplasma hominis

Published online by Cambridge University Press:  15 May 2009

D. M. Jones
Affiliation:
Public Health Laboratory Service, Withington Hospital, Manchester, 20
P. J. L. Sequeira
Affiliation:
Central Serology Laboratory, Manchester, 20
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sera from 3163 patients were examined for growth-inhibiting and complement-fixing antibody to Mycoplasma hominis. The results were analysed in respect of the age and sex of the patients. Antibodies were found to be uncommon in young people but increased in frequency with age; they were present in old men but were less common in women over sixty-five. Patients attending V.D. clinics and prison inmates had a much higher incidence of antibody than hospital and ante-natal patients. Complement-fixing antibody was approximately three times as common as growth-inhibiting antibody in the sample examined; it was also more common in women than men but the overall incidence of growth-inhibiting antibody was the same in each sex. It was concluded that possibly growth-inhibiting antibody is produced in more severe infections and that it disappears from the serum more quickly than complement-fixing antibody.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1966

References

REFERENCES

Andrews, B. E., (1965). Human infections with Mycoplasma pneumoniae (Eaton's agent). Proc. R. Soc. Med. 58, 80.Google Scholar
Card, D. H. (1959). PPLO of human genital origin; serological classification of strains and antibody distribution in man. Br. J. vener. Dis. 35, 27.Google ScholarPubMed
Grayston, J. T., Alexander, E. R., Kenny, G. E., Clarke, E. R., Fremont, J. C., & MacColl, W. A. (1965). Mycoplasma pneumoniae infections, clinical and epidemiologic studies. J. Am. med. Ass. 191, 369.CrossRefGoogle ScholarPubMed
Harkness, A. H. (1950). Non-gonoccocal Urethritis, Edinburgh: Livingstone.Google Scholar
Lemcke, R. & Csonka, G. W. (1962). Antibodies against pleuro-pneumonia-like organisms in patients with salpingitis. Br. J. vener. Dis. 38, 212.Google Scholar
Mufson, M. A., Ludwig, W. M., Purcell, R. H., Cate, T. R., Taylor-Robinson, D. & Chanock, R. M. (1965). Exudative pharyngitis following experimental Mycoplasma hominis Type I infection. J. Am. med. Ass. 192, 1146.CrossRefGoogle Scholar
Nicol, C. S. & Edward, D. G.ff. (1953). Role of organisms of the pleuro-pneumonia group in human genital infections. Br. J. vener. Dis. 29, 141Google Scholar
Randall, J. H., Stein, R. J. & Ayres, J. C. (1950). Pleuro-pneumonia-like organisms of the female genital tract. Am. J. Obstet. Gynec. 59, 404.CrossRefGoogle Scholar
Shepard, M. C. (1954). The recovery of pleuropneumonia-like organisms from negro men with and without non-gonococcal urethritis. Am. J. Syph. Gonorrhea vener. Dis. 38, 113.Google Scholar
Stokes, E. J. (1959). PPLO in genital infections. Br. med. J. i, 510.CrossRefGoogle Scholar
Taylor-Robinson, D., Ludwig, W. M., Purcell, R. H., Mufson, M. A. & Chanock, R. M. (1965). Significance of antibodies to Mycoplasma hominis Type I as measured by indirect haemagglutination. Proc. Soc. exp. Biol. Med. 118, 1073.CrossRefGoogle Scholar
Taylor-Robinson, D., Purcell, R. H., Wong, D. C. & Chanock, R. M. (1966). A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J. Hyg., Camb. 64, 91.CrossRefGoogle ScholarPubMed
Taylor-Robinson, D., Purcell, R. H. & Chanock, R. M. (1966). Metabolic-inhibition colour tests for Mycoplasma species. J. gen. Microbiol. 42, xii.Google Scholar